CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study

CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study

Background: COVID-19 pathophysiology and the predictive factors involved are not fully understood, but lymphocytes dysregulation appears to play a role. This paper aims to evaluate lymphocyte subsets in the pathophysiology of COVID-19 and as predictive factors for severe disease. Patient and methods...

Full description

Bibliographic Details
Main Authors: Joan Calvet, Jordi Gratacós, María José Amengual, Maria Llop, Marta Navarro, Amàlia Moreno, Antoni Berenguer-Llergo, Alejandra Serrano, Cristóbal Orellana, Manel Cervantes
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Viruses
Subjects:
COVID-19
lymphocyte subsets
CD4+ T cells
predictive value
severity
Online Access:https://www.mdpi.com/1999-4915/12/11/1277

Internet

https://www.mdpi.com/1999-4915/12/11/1277

Similar Items